Dark Forest Capital Management LP increased its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 180.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,905 shares of the real estate investment trust's stock after buying an additional 64,898 shares during the quarter. National Health Investors comprises 0.3% of Dark Forest Capital Management LP's portfolio, making the stock its 20th largest holding. Dark Forest Capital Management LP owned about 0.22% of National Health Investors worth $7,453,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. EP Wealth Advisors LLC grew its holdings in National Health Investors by 30.6% in the 1st quarter. EP Wealth Advisors LLC now owns 4,612 shares of the real estate investment trust's stock worth $341,000 after buying an additional 1,081 shares in the last quarter. Cubist Systematic Strategies LLC grew its holdings in National Health Investors by 130.5% in the 1st quarter. Cubist Systematic Strategies LLC now owns 30,236 shares of the real estate investment trust's stock worth $2,233,000 after buying an additional 17,118 shares in the last quarter. Graham Capital Management L.P. grew its holdings in National Health Investors by 10.1% in the 1st quarter. Graham Capital Management L.P. now owns 24,379 shares of the real estate investment trust's stock worth $1,801,000 after buying an additional 2,227 shares in the last quarter. Vident Advisory LLC grew its holdings in National Health Investors by 1.6% in the 1st quarter. Vident Advisory LLC now owns 12,691 shares of the real estate investment trust's stock worth $938,000 after buying an additional 201 shares in the last quarter. Finally, Corebridge Financial Inc. grew its holdings in National Health Investors by 3.1% in the 1st quarter. Corebridge Financial Inc. now owns 21,449 shares of the real estate investment trust's stock worth $1,584,000 after buying an additional 639 shares in the last quarter. 62.51% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on NHI. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective for the company in a report on Thursday, July 10th. Wells Fargo & Company upped their target price on National Health Investors from $76.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 27th. Truist Financial upped their target price on National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Finally, Wedbush upgraded National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, National Health Investors presently has an average rating of "Buy" and an average target price of $84.20.
View Our Latest Report on NHI
National Health Investors Price Performance
Shares of NYSE:NHI traded up $1.12 on Friday, reaching $78.34. 197,881 shares of the company traded hands, compared to its average volume of 194,460. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $86.13. The company's 50 day moving average is $73.34 and its 200-day moving average is $73.21. The stock has a market capitalization of $3.72 billion, a PE ratio of 25.03, a P/E/G ratio of 3.32 and a beta of 0.76. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The company had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. During the same quarter in the prior year, the firm earned $1.18 EPS. The company's quarterly revenue was up 6.7% compared to the same quarter last year. As a group, analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.92 per share. This is a boost from National Health Investors's previous quarterly dividend of $0.90. The ex-dividend date is Tuesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.7%. National Health Investors's payout ratio is currently 115.02%.
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.